These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 15892254

  • 1. No immediate pain relief for the pharmaceutical industry.
    Ahlborn H, Henderson S, Davies N.
    Curr Opin Drug Discov Devel; 2005 May; 8(3):384-91. PubMed ID: 15892254
    [Abstract] [Full Text] [Related]

  • 2. Do pharmaceutical prices respond to potential patient out-of-pocket expenses?
    Pavenik N.
    Rand J Econ; 2002 May; 33(3):469-87. PubMed ID: 12585303
    [Abstract] [Full Text] [Related]

  • 3. Antibacterial drug discovery: is it all downhill from here?
    Projan SJ, Shlaes DM.
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
    [Abstract] [Full Text] [Related]

  • 4. Ownership of knowledge--the role of patents in pharmaceutical R&D.
    Correa CM.
    Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
    [Abstract] [Full Text] [Related]

  • 5. The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace.
    Sollano JA, Kirsch JM, Bala MV, Chambers MG, Harpole LH.
    Clin Pharmacol Ther; 2008 Aug; 84(2):263-6. PubMed ID: 18547999
    [Abstract] [Full Text] [Related]

  • 6. Economics of new oncology drug development.
    DiMasi JA, Grabowski HG.
    J Clin Oncol; 2007 Jan 10; 25(2):209-16. PubMed ID: 17210942
    [Abstract] [Full Text] [Related]

  • 7. Indian generics companies go on spending spree.
    Jayaraman KS.
    Nat Rev Drug Discov; 2005 Aug 10; 4(8):616-7. PubMed ID: 16106583
    [No Abstract] [Full Text] [Related]

  • 8. New safe medicines faster: A proposal for a key action within the European union's 6th framework programme.
    Bjerrum OJ.
    Pharmacol Toxicol; 2000 Aug 10; 86 Suppl 1():23-6. PubMed ID: 10905750
    [Abstract] [Full Text] [Related]

  • 9. Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology.
    van der Greef J, McBurney RN.
    Nat Rev Drug Discov; 2005 Dec 10; 4(12):961-7. PubMed ID: 16341061
    [Abstract] [Full Text] [Related]

  • 10. [Economical evaluation of drugs. A steering method for the pharmaceutical sector of the 1990's?].
    Grund J, Husbyn H.
    Tidsskr Nor Laegeforen; 1994 Mar 20; 114(8):947-50. PubMed ID: 8191475
    [Abstract] [Full Text] [Related]

  • 11. Branded drug reformulation: the next brand vs. generic antitrust battleground.
    Amoresano GV.
    Food Drug Law J; 2007 Mar 20; 62(1):249-56. PubMed ID: 17444032
    [No Abstract] [Full Text] [Related]

  • 12. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
    Federsel HJ.
    Drug Discov Today; 2006 Nov 20; 11(21-22):966-74. PubMed ID: 17055405
    [Abstract] [Full Text] [Related]

  • 13. Surviving the blockbuster syndrome.
    Service RF.
    Science; 2004 Mar 19; 303(5665):1796-9. PubMed ID: 15031490
    [No Abstract] [Full Text] [Related]

  • 14. [Discount for only one drug of the same group leads to impaired health care quality].
    Bergström R.
    Lakartidningen; 2004 Mar 19; 103(6):387-8; discussion 388. PubMed ID: 16536044
    [No Abstract] [Full Text] [Related]

  • 15. Patent indicators: a window to pharmaceutical market success.
    Guo Y, Hu Y, Zheng M, Wang Y.
    Expert Opin Ther Pat; 2013 Jul 19; 23(7):765-71. PubMed ID: 23611022
    [Abstract] [Full Text] [Related]

  • 16. Examining the link between price regulation and pharmaceutical R&D investment.
    Vernon JA.
    Health Econ; 2005 Jan 19; 14(1):1-16. PubMed ID: 15386673
    [Abstract] [Full Text] [Related]

  • 17. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A, Martin P.
    Stud Hist Philos Biol Biomed Sci; 2006 Sep 19; 37(3):583-601. PubMed ID: 16980196
    [Abstract] [Full Text] [Related]

  • 18. The year's new drugs and biologics--2007.
    Graul AI, Prous JR, Barrionuevo M, Bozzo J, Castaner R, Cruces E, Revel L, Rosa E, Serradell N, Sorbera LA.
    Drug News Perspect; 2008 Sep 19; 21(1):7-35. PubMed ID: 18301807
    [Abstract] [Full Text] [Related]

  • 19. Searching for scalable processes: addressing the challenges in times of increasing complexity.
    Federsel HJ.
    Curr Opin Drug Discov Devel; 2003 Nov 19; 6(6):838-47. PubMed ID: 14758755
    [Abstract] [Full Text] [Related]

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 19; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.